Stryker Corp
NYSE:SYK
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
287.87
390.14
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Stryker Corp
Stryker Corp
Common Shares Outstanding
Stryker Corp
Common Shares Outstanding Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Stryker Corp
NYSE:SYK
|
Common Shares Outstanding
$381.2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Common Shares Outstanding
$289m
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
4%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Common Shares Outstanding
$1.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
1%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Common Shares Outstanding
$589.8m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-1%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Common Shares Outstanding
$1.7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Common Shares Outstanding
$356.2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
1%
|
|
Stryker Corp
Glance View
Stryker Corporation, a prominent player in the global medical technology landscape, has carved out a reputation for innovation and reliability since its founding in 1941. Specializing in developing and manufacturing a diverse range of products, Stryker's offerings span surgical equipment, implantable devices, and medical instruments, all designed to enhance patient care and improve clinical outcomes. Fueled by a commitment to quality and continuous improvement, the company invests heavily in research and development, leading the way with cutting-edge technologies like robotic surgical systems and advanced orthopedic solutions. The company’s strong market position is bolstered by its strategic acquisitions, which not only expand its product portfolio but also deepen its penetration into key medical segments, allowing Stryker to sustain impressive growth rates. For investors, Stryker represents a compelling opportunity in the healthcare sector, driven by the increasing demand for advanced medical solutions in an aging global population. With a presence in over 100 countries, Stryker's diversified revenue streams reduce risk and enhance resilience against market fluctuations. The company consistently delivers solid financial performance, characterized by robust margins and healthy cash flows, which it strategically reinvests to fuel future growth. Furthermore, its strong commitment to sustainability and corporate responsibility positions Stryker favorably in a market increasingly concerned with ethical practices. As the healthcare industry continues to evolve, Stryker’s innovative edge and solid fundamentals make it a captivating prospect for investors seeking long-term stability and growth.
See Also
What is Stryker Corp's Common Shares Outstanding?
Common Shares Outstanding
381.2m
USD
Based on the financial report for Sep 30, 2024, Stryker Corp's Common Shares Outstanding amounts to 381.2m USD.
What is Stryker Corp's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
0%
Over the last year, the Common Shares Outstanding growth was 0%.
You don't have any saved screeners yet
